FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4324149016> ?p ?o ?g. }

• W4324149016 endingPage "647" @default.
• W4324149016 startingPage "647" @default.
• W4324149016 abstract "Understanding past successes in reaching unvaccinated or zero-dose children can help inform strategies for improving childhood immunization in other settings. Drawing from positive outlier methods, we developed a novel approach for identifying potential exemplars in reducing zero-dose children.Focusing on 2000-2019, we assessed changes in the percentage of under-one children with no doses of the diphtheria-tetanus-pertussis vaccine (no-DTP) across two geographic dimensions in 56 low- or lower-middle-income countries: (1) national levels; (2) subnational gaps, as defined as the difference between the 5th and 95th percentiles of no-DTP prevalence across second administrative units. Countries with the largest reductions for both metrics were considered positive outliers or potential 'exemplars', demonstrating exception progress in reducing national no-DTP prevalence and subnational inequalities. Last, so-called neighborhood analyses were conducted for the Gavi Learning Hub countries (Nigeria, Mali, Uganda, and Bangladesh), comparing them with countries that had similar no-DTP measures in 2000 but different trajectories through 2019.From 2000 to 2019, the Democratic Republic of the Congo, Ethiopia, and India had the largest absolute decreases for the two no-DTP dimensions-national prevalence and subnational gaps-while Bangladesh and Burundi registered the largest relative reductions for each no-DTP metric. Neighborhood analyses highlighted possible opportunities for cross-country learning among Gavi Learning Hub countries and potential exemplars in reducing zero-dose children.Identifying where exceptional progress has occurred is the first step toward better understanding how such gains could be achieved elsewhere. Further examination of how countries have successfully reduced levels of zero-dose children-especially across variable contexts and different drivers of inequality-could support faster, sustainable advances toward greater vaccination equity worldwide." @default.
• W4324149016 created "2023-03-15" @default.
• W4324149016 creator A5050352306 @default.
• W4324149016 creator A5069378251 @default.
• W4324149016 creator A5072270358 @default.
• W4324149016 creator A5074421134 @default.
• W4324149016 creator A5082680670 @default.
• W4324149016 date "2023-03-14" @default.
• W4324149016 modified "2023-09-26" @default.
• W4324149016 title "Assessing Potential Exemplars in Reducing Zero-Dose Children: A Novel Approach for Identifying Positive Outliers in Decreasing National Levels and Geographic Inequalities in Unvaccinated Children" @default.
• W4324149016 cites W1965905958 @default.
• W4324149016 cites W1992181182 @default.
• W4324149016 cites W2019469924 @default.
• W4324149016 cites W2047196134 @default.
• W4324149016 cites W2051319790 @default.
• W4324149016 cites W2087936447 @default.
• W4324149016 cites W2103201679 @default.
• W4324149016 cites W2119497907 @default.
• W4324149016 cites W2134344922 @default.
• W4324149016 cites W2148364666 @default.
• W4324149016 cites W2155772921 @default.
• W4324149016 cites W2275486550 @default.
• W4324149016 cites W2406625885 @default.
• W4324149016 cites W2508424442 @default.
• W4324149016 cites W2513901369 @default.
• W4324149016 cites W2545941140 @default.
• W4324149016 cites W2614986146 @default.
• W4324149016 cites W2765081836 @default.
• W4324149016 cites W2931516094 @default.
• W4324149016 cites W2936342662 @default.
• W4324149016 cites W2964805926 @default.
• W4324149016 cites W3041367236 @default.
• W4324149016 cites W3084350025 @default.
• W4324149016 cites W3108364113 @default.
• W4324149016 cites W3123481858 @default.
• W4324149016 cites W3137868160 @default.
• W4324149016 cites W3172082902 @default.
• W4324149016 cites W3183723118 @default.
• W4324149016 cites W3197673829 @default.
• W4324149016 cites W3214314854 @default.
• W4324149016 cites W3217403024 @default.
• W4324149016 cites W4200361655 @default.
• W4324149016 cites W4221066955 @default.
• W4324149016 cites W4224242297 @default.
• W4324149016 cites W4224991993 @default.
• W4324149016 cites W4225153444 @default.
• W4324149016 cites W4225547428 @default.
• W4324149016 cites W4280637014 @default.
• W4324149016 cites W4282830643 @default.
• W4324149016 cites W4283378927 @default.
• W4324149016 cites W4283744220 @default.
• W4324149016 cites W4289338318 @default.
• W4324149016 cites W4293190820 @default.
• W4324149016 cites W4294796648 @default.
• W4324149016 cites W4296755075 @default.
• W4324149016 cites W4307309179 @default.
• W4324149016 cites W4307372108 @default.
• W4324149016 cites W4311015193 @default.
• W4324149016 doi "https://doi.org/10.3390/vaccines11030647" @default.
• W4324149016 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36992231" @default.
• W4324149016 hasPublicationYear "2023" @default.
• W4324149016 type Work @default.
• W4324149016 citedByCount "1" @default.
• W4324149016 countsByYear W43241490162023 @default.
• W4324149016 crossrefType "journal-article" @default.
• W4324149016 hasAuthorship W4324149016A5050352306 @default.
• W4324149016 hasAuthorship W4324149016A5069378251 @default.
• W4324149016 hasAuthorship W4324149016A5072270358 @default.
• W4324149016 hasAuthorship W4324149016A5074421134 @default.
• W4324149016 hasAuthorship W4324149016A5082680670 @default.
• W4324149016 hasBestOaLocation W43241490161 @default.
• W4324149016 hasConcept C105795698 @default.
• W4324149016 hasConcept C134306372 @default.
• W4324149016 hasConcept C144024400 @default.
• W4324149016 hasConcept C149923435 @default.
• W4324149016 hasConcept C205649164 @default.
• W4324149016 hasConcept C33923547 @default.
• W4324149016 hasConcept C45555294 @default.
• W4324149016 hasConcept C71924100 @default.
• W4324149016 hasConcept C79337645 @default.
• W4324149016 hasConcept C99454951 @default.
• W4324149016 hasConceptScore W4324149016C105795698 @default.
• W4324149016 hasConceptScore W4324149016C134306372 @default.
• W4324149016 hasConceptScore W4324149016C144024400 @default.
• W4324149016 hasConceptScore W4324149016C149923435 @default.
• W4324149016 hasConceptScore W4324149016C205649164 @default.
• W4324149016 hasConceptScore W4324149016C33923547 @default.
• W4324149016 hasConceptScore W4324149016C45555294 @default.
• W4324149016 hasConceptScore W4324149016C71924100 @default.
• W4324149016 hasConceptScore W4324149016C79337645 @default.
• W4324149016 hasConceptScore W4324149016C99454951 @default.
• W4324149016 hasIssue "3" @default.
• W4324149016 hasLocation W43241490161 @default.
• W4324149016 hasLocation W43241490162 @default.
• W4324149016 hasLocation W43241490163 @default.
• W4324149016 hasOpenAccess W4324149016 @default.
• W4324149016 hasPrimaryLocation W43241490161 @default.
• W4324149016 hasRelatedWork W1506200166 @default.

• next